Company Insider Tape

Harvard Bioscience Inc insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol HBIO Latest filing 9 Jun 2026

Company Read

Acquisition-led

HBIO has 5 stored insider filings. Acquisitions account for 100.0% of classified filings and disposals account for 0.0%.

Latest filing 9 Jun 2026most recent stored row
Largest filing $0reported transaction value
Total filings 5stored transaction rows
Acquisition value $05 acquisitions
Disposal value $00 disposals
Net value $0acquisitions minus disposals

Filing cadence

Last 12 active months
Jun 2026 5

Acquisitions 100.0% · Disposals 0.0%

Jun 2026 $0

Executive concentration

By filing count
BENSON, SETH BENJAMIN Director · 1 filings
DENELSKY, STEPHEN J Director · 1 filings
EADE, KATHERINE A. Director · 1 filings
GAGNON, ROBERT E. Director · 1 filings
SNIDER, WILLIAM Director · 1 filings

Market Context

HBIO weekly market snapshot

Week 31 Jul 2026
Latest close 6.10 USDstored weekly close
1-week move +1.7%latest weekly bar
13-week move -0.8%medium-term context
Relative Strength -1.6Sharemaestro indicator
Fair value gap -70.1%price vs fair value
Trend signal 1smoothed trend state

Transaction History

Latest insider filings for HBIO

Showing 1-5 of 5
Date 9 Jun 2026
Insider BENSON, SETH BENJAMINDirector
Side Acquisition
Shares 16556
Price 0.00
Value 0
Security Common Stock
Date 9 Jun 2026
Insider DENELSKY, STEPHEN JDirector
Side Acquisition
Shares 16556
Price 0.00
Value 0
Security Common Stock
Date 9 Jun 2026
Insider EADE, KATHERINE A.Director
Side Acquisition
Shares 16556
Price 0.00
Value 0
Security Common Stock
Date 9 Jun 2026
Insider GAGNON, ROBERT E.Director
Side Acquisition
Shares 16556
Price 0.00
Value 0
Security Common Stock
Date 9 Jun 2026
Insider SNIDER, WILLIAMDirector
Side Acquisition
Shares 16556
Price 0.00
Value 0
Security Common Stock